{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:25:07Z","timestamp":1667175907437},"reference-count":85,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.anndiagpath.2005.10.001","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T19:07:22Z","timestamp":1137697642000},"page":"39-65","source":"Crossref","is-referenced-by-count":8,"title":["Advances in the pathologic diagnosis and biology of acute myeloid leukemia"],"prefix":"10.1016","volume":"10","author":[{"given":"Sergej","family":"Konoplev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E.","family":"Bueso-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2005.10.001_bib1","series-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues","first-page":"75","article-title":"Acute myeloid leukemia","author":"Brunning","year":"2000"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib2","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/modpathol.3880077","article-title":"Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases","volume":"13","author":"Zhang","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib4","first-page":"34","article-title":"Effects of short-term in vivo administration of G-CSF on bone marrow prior to harvesting","volume":"25","author":"Dicke","year":"1997","journal-title":"Exp Hematol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib5","first-page":"696","article-title":"Effect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromes","volume":"7","author":"Ganser","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib6","first-page":"79","article-title":"Bone marrow changes in patients with refractory aplastic anemia treated by recombinant GM-CSF","volume":"4","author":"Naeim","year":"1990","journal-title":"Hematol Pathol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib7","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1182\/blood.V57.6.1068.bloodjournal5761068","article-title":"Acute nonlymphocytic leukemia: heterogeneity of stem cell origin","volume":"57","author":"Fialkow","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib8","series-title":"SEER Cancer statistics review, 1973-1999","author":"Ries","year":"2002"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/1097-0142(19950101)75:1+<381::AID-CNCR2820751320>3.0.CO;2-B","article-title":"Leukemias, myeloma, and other lymphoreticular neoplasms","volume":"75","author":"Hernandez","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib10","first-page":"475","article-title":"Leukaemia","volume":"19-20","author":"Kinlen","year":"1994","journal-title":"Cancer Surv"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib11","series-title":"Leukemia","first-page":"131","article-title":"Epidemiology of leukemia: overview and patterns of epidemiology of leukemia: overview and patterns of occurrence","author":"Linet","year":"2002"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib12","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1182\/blood.V87.1.308.308","article-title":"High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia","volume":"87","author":"Douer","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(70)91032-9","article-title":"45,XO Turner's syndrome and leukaemia","volume":"1","author":"Wertelecki","year":"1970","journal-title":"Lancet"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0031-3955(16)36513-0","article-title":"Preleukemic syndromes and other syndromes predisposing to leukemia","volume":"35","author":"Schwartz","year":"1988","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2307\/3575833","article-title":"Studies of the mortality of A-bomb survivors. Report 7. Mortality, 1950-1978: Part II. Mortality from causes other than cancer and mortality in early entrants","volume":"91","author":"Kato","year":"1982","journal-title":"Radiat Res"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib16","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.2188\/jea.6.3sup_95","article-title":"A long-term cohort study of the atomic-bomb survivors","volume":"6","author":"Kodama","year":"1996","journal-title":"J Epidemiol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/10428199309054725","article-title":"A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias","volume":"11","author":"Ellis","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib18","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood.V65.6.1364.bloodjournal6561364","article-title":"Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases","volume":"65","author":"Michels","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib19","first-page":"1990","article-title":"Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases","volume":"9","author":"Pui","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib20","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/jnci\/82.23.1832","article-title":"History of cigarette smoking and risk of leukemia and myeloma: results from the Adventist health study","volume":"82","author":"Mills","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib21","series-title":"Wintrobe's clinical hematology","first-page":"1725","article-title":"Classification, pathogenesis, and etiology of neoplastic diseases of the hematopoietic system","author":"Sullivan","year":"1993"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00005792-196209000-00001","article-title":"The acute leukemias. Analysis of 322 cases and review of the literature","volume":"41","author":"Boggs","year":"1962","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1182\/blood.V49.3.345.345","article-title":"Electrolyte and acid-base disturbances in the management of leukemia","volume":"49","author":"O'Regan","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib24","series-title":"Neoplastic Diseases of the Blood","first-page":"331","article-title":"Diagnosis and treatment of adult acute myelocytic leukemia","author":"Wiernik","year":"1996"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/blood.V60.2.279.279","article-title":"Hyperleukocytic leukemias: rheological, clinical, and therapeutic considerations","volume":"60","author":"Lichtman","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib26","series-title":"Chronic and Acute Leukemias in Adults","first-page":"263","article-title":"Hyperleukocytosis in adult leukemias","author":"Cuttner","year":"1985"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1182\/blood.V40.5.709.709","article-title":"Intravascular coagulation in acute leukemia: clinical and subclinical abnormalities","volume":"40","author":"Gralnick","year":"1972","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0889-8588(05)70347-6","article-title":"Coagulation disorders in cancer","volume":"10","author":"Goad","year":"1996","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-0038-1647454","article-title":"Tissue factor released from leukemic cells","volume":"65","author":"Kubota","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib30","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1200\/JCO.1986.4.8.1212","article-title":"The clinical and biological correlates of coagulopathy in children with acute leukemia","volume":"4","author":"Ribeiro","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2141.1988.tb07629.x","article-title":"Diagnostic and prognostic factors in acute monocytic leukaemia: an analysis of 51 cases","volume":"69","author":"Scott","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/hon.2900040202","article-title":"An immunohistochemical and clinicopathological study of granulocytic sarcoma (\u2018chloroma\u2019)","volume":"4","author":"Muller","year":"1986","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib33","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/1097-0142(19810915)48:6<1426::AID-CNCR2820480626>3.0.CO;2-G","article-title":"Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases","volume":"48","author":"Neiman","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib34","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/1097-0142(19860915)58:6<1260::AID-CNCR2820580614>3.0.CO;2-O","article-title":"Myeloblastoma with an 8;21 chromosome translocation in acute myeloblastic leukemia","volume":"58","author":"Abe","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib35","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/1097-0142(19860301)57:5<1005::AID-CNCR2820570523>3.0.CO;2-P","article-title":"Granulocytic sarcoma with an indolent course and destructive skeletal disease. Tumor characterization with immunologic markers, electron microscopy, cytochemistry, and cytogenetic studies","volume":"57","author":"Welch","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1309\/NXLCJ1B16YDFQWND","article-title":"Myeloid sarcoma involving the testis","volume":"124","author":"Valbuena","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1524-4741.2004.09612.x","article-title":"Granulocytic sarcoma (chloroma) of the breast: a diagnostic dilemma and review of the literature","volume":"10","author":"Shea","year":"2004","journal-title":"Breast J"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib38","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/sj.leu.2402958","article-title":"Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy","volume":"17","author":"Tsimberidou","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib39","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00043426-200310000-00004","article-title":"Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group","volume":"25","author":"Dusenbery","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib40","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1002\/(SICI)1097-0142(19961215)78:12<2510::AID-CNCR10>3.0.CO;2-Z","article-title":"Extramedullary acute promyelocytic leukemia","volume":"78","author":"Wiernik","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib41","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/1097-0142(19861215)58:12<2697::AID-CNCR2820581225>3.0.CO;2-R","article-title":"Granulocytic sarcoma in nonleukemic patients","volume":"58","author":"Meis","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib42","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/modpathol.3800481","article-title":"Analysis of loss of heterozygosity and X chromosome inactivation in spleens with myeloproliferative disorders and acute myeloid leukemia","volume":"18","author":"O'Malley","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib43","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","article-title":"Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2002-09-2768","article-title":"Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation","volume":"102","author":"Wells","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib45","doi-asserted-by":"crossref","first-page":"460","DOI":"10.7326\/0003-4819-103-3-460","article-title":"Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib46","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1038\/sj.leu.2401214","article-title":"The value of c-kit in the diagnosis of biophenotypic acute leukemia (European Group for the Immunological Classification of Leukemias)","volume":"12","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib47","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib48","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0037-1963(01)90046-0","article-title":"Flow cytometry in the diagnosis of acute leukemia","volume":"38","author":"Weir","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib49","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.5858\/2003-127-1140-UCFCTI","article-title":"Using 4-color flow cytometry to identify abnormal myeloid populations","volume":"127","author":"Kussick","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib50","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1309\/6PBP78G4FBA1FDG6","article-title":"Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia","volume":"124","author":"Kussick","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.anndiagpath.2005.10.001_bib51","first-page":"S97","article-title":"Genetic classification of acute myeloid leukemia (AML)","volume":"83","author":"Haferlach","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib52","first-page":"3931","article-title":"Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8364","volume":"93","author":"Czuczman","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib53","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.leu.2402135","article-title":"An atlas of chromosomes in hematological malignancies example: 11q23 and MLL partners","volume":"15","author":"Huret","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0268-960X(03)00040-7","article-title":"Cytogenetics in acute leukemia","volume":"18","author":"Mrozek","year":"2004","journal-title":"Blood Rev"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/asheducation-2002.1.73","article-title":"Acute myeloid leukemia","author":"Giles","year":"2002","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib56","first-page":"28","article-title":"Advances in understanding the biology and genetics of acute myelocytic leukemia","volume":"18","author":"McKenzie","year":"2005","journal-title":"Clin Lab Sci"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","article-title":"Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series","volume":"102","author":"Smith","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib58","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1182\/blood-2004-12-4938","article-title":"Global approach to the diagnosis of leukemia using gene expression profiling","volume":"106","author":"Haferlach","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib59","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood.V98.6.1752","volume":"98","author":"Kottaridis","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib60","first-page":"7233","article-title":"Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a Cancer and Leukemia Group B Study","volume":"61","author":"Whitman","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib61","first-page":"55","article-title":"Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics","volume":"58","author":"Caligiuri","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib62","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1200\/JCO.2002.09.088","article-title":"Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm","volume":"20","author":"Dohner","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib63","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-03-0990","article-title":"Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)","volume":"100","author":"Preudhomme","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib64","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1182\/blood-2003-02-0359","article-title":"BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study","volume":"102","author":"Baldus","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib65","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1200\/JCO.2003.08.005","volume":"21","author":"Haferlach","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib66","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1182\/blood.V90.8.2969","article-title":"Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy","volume":"90","author":"Estey","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib67","first-page":"733","article-title":"Independent prognostic significance of day 21 cytogenetic findings in newly-diagnosed acute myeloid leukemia or refractory anemia with excess blasts","volume":"88","author":"Konopleva","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib68","first-page":"500","article-title":"Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia","volume":"6","author":"Freireich","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib69","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1200\/JCO.2004.03.023","article-title":"Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from Cancer and Leukemia Group B Study 8461","volume":"22","author":"Marcucci","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib70","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood-2002-10-3064","article-title":"Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia","volume":"101","author":"Sievers","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib71","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1182\/blood.V97.11.3574","article-title":"High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)","volume":"97","author":"Baer","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib72","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/blood.V98.6.1746","article-title":"Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification","volume":"98","author":"San Miguel","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib73","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1034\/j.1600-0609.2003.00131.x","article-title":"Core binding factor (CBF) acute myeloid leukemia: is molecular monitoring by RT-PCR useful clinically?","volume":"71","author":"Marcucci","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib74","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000077559","article-title":"Detection of minimal residual disease in acute myelogenous leukemia","volume":"112","author":"Raanani","year":"2004","journal-title":"Acta Haematol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib75","first-page":"1283","article-title":"Cytogenetic findings in acute biphenotypic leukaemia","volume":"10","author":"Carbonell","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib76","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/sj.leu.2401229","article-title":"Biologic heterogeneity in Philadelphia chromosome\u2013positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience","volume":"12","author":"Paietta","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib77","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2141.1994.tb04869.x","article-title":"Late-appearing Philadelphia chromosome in a patient with acute nonlymphocytic leukaemia derived from myelodysplastic syndrome: detection of P210- and P190-type bcr\/abl fusion gene transcripts at the leukaemic stage","volume":"87","author":"Katsuno","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib78","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1309\/GJWNPD8HU5MAJ837","article-title":"Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review","volume":"123","author":"Petrella","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib79","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/pbc.20200","article-title":"Metastatic malignant melanoma presenting as pancytopenia in a three-year-old boy","volume":"45","author":"Spiller","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajh.1148","article-title":"Hematologic masquerade of rhabdomyosarcoma","volume":"68","author":"Sandberg","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/mpo.2950170108","article-title":"Rhabdomyosarcoma, presenting as disseminated malignancy from an unknown primary site: a retrospective study of ten pediatric cases","volume":"17","author":"Etcubanas","year":"1989","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib82","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00043426-199711000-00001","article-title":"Molecular genetics and pathogenesis of rhabdomyosarcoma","volume":"19","author":"Barr","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib83","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/329645a0","article-title":"Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping","volume":"329","author":"Scrable","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib84","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1056\/NEJM199408043310503","article-title":"The Ewing family of tumors\u2014a subgroup of small-round-cell tumors defined by specific chimeric transcripts","volume":"331","author":"Delattre","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anndiagpath.2005.10.001_bib85","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1008271610208","article-title":"Does bone marrow involvement affect prognosis in small-cell lung cancer?","volume":"9","author":"Pasini","year":"1998","journal-title":"Ann Oncol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913405001838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913405001838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T21:16:33Z","timestamp":1626988593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913405001838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S1092913405001838"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2005.10.001","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}